<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01824745</url>
  </required_header>
  <id_info>
    <org_study_id>12383</org_study_id>
    <secondary_id>NCI-2013-00734</secondary_id>
    <nct_id>NCT01824745</nct_id>
  </id_info>
  <brief_title>Survivorship Care Planning in Improving the Quality of Life in Breast Cancer Survivors</brief_title>
  <official_title>Survivorship Care Planning for At Risk Breast Cancer Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>City of Hope Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>City of Hope Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized pilot clinical trial studies survivorship care planning in improving the
      quality of life in breast cancer survivors. Survivorship care planning may reduce stress and
      improve the well-being and quality of life of cancer survivors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:

      I. Test the effectiveness of the navigation intervention and survivorship care plan
      (SCP)-breast cancer survivors (BCS) template booklet on accessing and adhering to SCP-BCS
      guidelines compared to the control group receiving usual care and the SCP-BCS template
      booklet.

      SECONDARY OBJECTIVES:

      I. Develop a clinically and psychosocially responsive SCP-breast cancer survivors (SCP-BCS)
      template in English and English-Spanish adopted from American Society of Clinical Oncology
      (ASCO)-SCP.

      II. Assess the acceptability, utility and format preference (electronic vs paper) of the
      SCP-BCS template.

      OUTLINE: Participants are randomized to 1 of 2 arms.

      ARM I: Participants receive SCP-BCS template booklet and receive counseling sessions with a
      patient navigator for 40 minutes twice weekly for 4 sessions.

      ARM II: Participants receive SCP-BCS template booklet and receive standard follow-up care.

      After completion so study treatment, participants are followed up at 6 and 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 15, 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of BCS accessing a SCP from their oncology provider</measure>
    <time_frame>At 6 months</time_frame>
    <description>Fisher's exact test will be used to test the null hypothesis (at least 40% of trial participants will have access to SCP).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adherence to SCP guidelines</measure>
    <time_frame>At 12 months</time_frame>
    <description>Fisher's exact test will be used to test the null hypothesis (at least 25% of participants reporting adherence to SCP guidelines).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of BCS accessing a SCP from their oncology provider</measure>
    <time_frame>At 12 months</time_frame>
    <description>Fisher's exact test will be used to test the null hypothesis (at least 60% of trial participants will have access to SCP).</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Develop a clinically and psychosocially responsive SCP-BCS template in English and a linguistically response bilingual version (English-Spanish)</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>The acceptability, utility, and format preference will also be assessed. A rating score will be generated for acceptability and utility and 95% confidence intervals for the proportion of BCS rating score at &gt;= 4 will be assessed.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Cancer Survivor</condition>
  <arm_group>
    <arm_group_label>Arm I (SCP-BCS template booklet and counseling)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive SCP-BCS template booklet and receive counseling sessions with a patient navigator for 40 minutes twice weekly for 4 sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm II (SCP-BCS template booklet)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants receive SCP-BCS template booklet and receive standard follow-up care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>educational intervention</intervention_name>
    <description>Receive the SCP-BCS template booklet</description>
    <arm_group_label>Arm I (SCP-BCS template booklet and counseling)</arm_group_label>
    <arm_group_label>Arm II (SCP-BCS template booklet)</arm_group_label>
    <other_name>intervention, educational</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>counseling intervention</intervention_name>
    <description>Receive counseling sessions with a patient navigator</description>
    <arm_group_label>Arm I (SCP-BCS template booklet and counseling)</arm_group_label>
    <other_name>counseling and communications studies</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>standard follow-up care</intervention_name>
    <description>Receive standard follow-up care</description>
    <arm_group_label>Arm II (SCP-BCS template booklet)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>quality-of-life assessment</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Arm I (SCP-BCS template booklet and counseling)</arm_group_label>
    <arm_group_label>Arm II (SCP-BCS template booklet)</arm_group_label>
    <other_name>quality of life assessment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnaire administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Arm I (SCP-BCS template booklet and counseling)</arm_group_label>
    <arm_group_label>Arm II (SCP-BCS template booklet)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  In early survivorship phase, defined as being post-surgery to ending of active
             treatment to 18 months post active treatment for stage 0-3 breast cancer (BCA)

          -  Reside in Southern California

          -  BCS treated at Kaiser, an health maintenance organization (HMO) provider, will be
             excluded since their SCP implementation project is underway

          -  BCS will not be excluded based on cancer treatments received or a history of diagnosis
             of mild depression, anxiety, and hypertension and diabetes
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kimlin Ashing-Giwa</last_name>
    <role>Principal Investigator</role>
    <affiliation>City of Hope Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>City of Hope Medical Center</name>
      <address>
        <city>Duarte</city>
        <state>California</state>
        <zip>91010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City of Hope Antelope Valley</name>
      <address>
        <city>Lancaster</city>
        <state>California</state>
        <zip>93534</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 2, 2013</study_first_submitted>
  <study_first_submitted_qc>April 2, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 5, 2013</study_first_posted>
  <last_update_submitted>March 14, 2018</last_update_submitted>
  <last_update_submitted_qc>March 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

